MiR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Borralho, Pedro M ^a   Simões, André E S ^a   Gomes, Sofia E ^a   Lima, Raquel T ^b   Carvalho, Tânia ^c,d   Ferreira, Duarte M S ^a   Vasconcelos, Maria H ^b   Castro, Rui E ^a   Rodrigues, Cecília M P ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^d INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; MICRORNA; MICRORNA 143; MITOGEN ACTIVATED PROTEIN KINASE 7; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; UNCLASSIFIED DRUG; MIRN143 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; TUMOR XENOGRAFT; ANIMAL; COLON TUMOR; DRUG SCREENING; GENETICS; METABOLISM; NICK END LABELING; NUDE MOUSE; PHYSIOLOGY;

MUS; MUS MUSCULUS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, NUDE; MICRORNAS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052061782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023787     Document Type: Article

References (48)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
3. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
4. Carthew RW, (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16: 203-208.
5. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA, et al. (2011) MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 47: 163-174.
6. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, et al. (2009) Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401.
7. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
8. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, et al. (2011) miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer. PLoS One 6: e20465.
9. Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, et al. (2010) Role of anti-oncomirs miR-143 and-145 in human colorectal tumors. Cancer Gene Ther 17: 398-408.
10. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ, (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
11. Akao Y, Nakagawa Y, Naoe T, (2006) MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 16: 845-850.
12. Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, et al. (2009) MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 276: 6689-6700.
13. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T, (2007) Downregulation of microRNAs-143 and-145 in B-cell malignancies. Cancer Sci 98: 1914-1920.
14. Navarro A, Diaz T, Gallardo E, Vinolas N, Marrades RM, et al. (2011) Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol 103: 411-415.
15. Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF, et al. (2011) MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol 17: 79-88.
16. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, et al. (2010) MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 97: 853-861.
17. Zhang H, Cai X, Wang Y, Tang H, Tong D, et al. (2010) microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24: 1363-1369.
18. Lin T, Dong W, Huang J, Pan Q, Fan X, et al. (2009) MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 181: 1372-1380.
19. Lui WO, Pourmand N, Patterson BK, Fire A, (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043.
20. Clape C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, et al. (2009) miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 4: e7542.
21. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, et al. (2009) Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 77: 12-21.
22. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, et al. (2009) Modulation of microRNA processing by p53. Nature 460: 529-533.
23. Chen X, Guo X, Zhang H, Xiang Y, Chen J, et al. (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385-1392.
24. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, et al. (2009) MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706.
25. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
26. Szczyrba J, Loprich E, Wach S, Jung V, Unteregger G, et al. (2010) The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 8: 529-538.
27. Akao Y, Nakagawa Y, Iio A, Naoe T, (2009) Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk Res 33: 1530-1538.
28. Borralho PM, Moreira da Silva IB, Aranha MM, Albuquerque C, Nobre Leitao C, et al. (2007) Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53. Biochim Biophys Acta 1772: 40-47.
29. Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, et al. (2004) The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. Clin Cancer Res 10: 3562-3571.
30. Wang X, Tournier C, (2006) Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal 18: 753-760.
31. Aranha MM, Borralho PM, Ravasco P, Moreira da Silva IB, Correia L, et al. (2007) NF-kappaB and apoptosis in colorectal tumourigenesis. Eur J Clin Invest 37: 416-424.
32. Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, et al. (2009) Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 15: 2248-2258.
33. Pearson G, English JM, White MA, Cobb MH, (2001) ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. J Biol Chem 276: 7927-7931.
34. Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, et al. (2007) Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. J Cell Biol 177: 253-264.
35. Voboril R, Hochwald SN, Li J, Brank A, Weberova J, et al. (2004) Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer. J Surg Res 120: 178-188.
36. Girio A, Montero JC, Pandiella A, Chatterjee S, (2007) Erk5 is activated and acts as a survival factor in mitosis. Cell Signal 19: 1964-1972.
37. Pekow JR, Dougherty U, Mustafi R, Zhu H, Kocherginsky M, et al. (2011) miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis May 6 doi:10.1002/ibd.21742. [Epub ahead of print].
38. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
39. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102: 3627-3632.
40. Gokhale A, Kunder R, Goel A, Sarin R, Moiyadi A, et al. (2010) Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther 6: 521-529.
41. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, et al. (2008) Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542.
42. Letzen BS, Liu C, Thakor NV, Gearhart JD, All AH, et al. (2010) MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells. PLoS One 5: e10480.
43. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, et al. (2010) A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 24: 447-463.
44. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139.
45. Garaude J, Cherni S, Kaminski S, Delepine E, Chable-Bessia C, et al. (2006) ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo. J Immunol 177: 7607-7617.
46. Li Z, Li J, Mo B, Hu C, Liu H, et al. (2008) Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol In Vitro 22: 1749-1753.
47. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, et al. (2001) Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20: 5025-5032.
48. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, et al. (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279: 52361-52365.